1. Dexamethasone is a dose-dependent perpetrator of drug–drug interactions: implications for use in people living with HIV. (17th November 2021) Authors: Jacobs, Tom G; Marzolini, Catia; Back, David J; Burger, David M Journal: Journal of antimicrobial chemotherapy Issue: Volume 77:Number 3(2022) Page Start: 568 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Fluvoxamine for the treatment of COVID-19. Issue 3 (March 2022) Authors: Marzolini, Catia; Marra, Fiona; Boyle, Alison; Khoo, Saye; Back, David J Journal: Lancet Issue: Volume 10:Issue 3(2022) Page Start: e331 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Non-disclosure of HIV status in UK sexual health clinics—a pilot study to identify non-disclosure within a national unlinked anonymous seroprevalence survey. Issue 2 (13th February 2013) Authors: Sullivan, Ann Kathleen; Savage, Emma J; Lowndes, Catherine M; Paul, George; Murphy, Gary; Carne, Simon; Back, David J; Gill, O Noel Journal: Sexually transmitted infections Issue: Volume 89:Issue 2(2013) Page Start: 120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Physiologically based pharmacokinetic modelling prediction of the effects of dose adjustment in drug–drug interactions between levonorgestrel contraceptive implants and efavirenz-based ART. (22nd January 2018) Authors: Roberts, Owain; Rajoli, Rajith K R; Back, David J; Owen, Andrew; Darin, Kristin M; Fletcher, Courtney V; Lamorde, Mohammed; Scarsi, Kimberly K; Siccardi, Marco Journal: Journal of antimicrobial chemotherapy Issue: Volume 73:Number 4(2018) Page Start: 1004 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Quantification of rilpivirine in human plasma, cervicovaginal fluid, rectal fluid and genital/rectal mucosal tissues using liquid chromatography–tandem mass spectrometry. (July 2014) Authors: Else, Laura J; Tjia, John; Jackson, Akil; Penchala, Sujan Dilly; Egan, Deirdre; Boffito, Marta; Khoo, Saye H; Back, David J Journal: Bioanalysis Issue: Volume 6:Number 14(2014) Page Start: 1907 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Telmisartan reverses antiretroviral-induced adipocyte toxicity and insulin resistance in vitro. (May 2018) Authors: Pushpakom, Sudeep P; Adaikalakoteswari, Antonysunil; Owen, Andrew; Back, David J; Tripathi, Gyanendra; Kumar, Sudhesh; McTernan, Philip; Pirmohamed, Munir Journal: Diabetes & vascular disease research Issue: Volume 15:Number 3(2018:May) Page Start: 233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The challenging pathway towards the identification of SARS-CoV-2/COVID-19 therapeutics. (26th June 2020) Authors: Siccardi, Marco; Schapiro, Jonathan; Di Perri, Giovanni; Back, David J Journal: Journal of antimicrobial chemotherapy Issue: Volume 75:Number 9(2020) Page Start: 2381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Widespread use of herbal medicines by people living with human immunodeficiency virus and contamination of herbal medicines with antiretrovirals in Nigeria. (March 2019) Authors: Gini, J; Amara, A; Penchala, Sujan D; Back, David J; Else, L; Egan, D; Chiong, J; Harri, Bala I; Kabilis, Elkanah D; Pama, Paul P; Stephen, M; Khoo, Saye H Journal: International journal of STD & AIDS Issue: Volume 30:Number 4(2019) Page Start: 371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗